UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
Webpage Links
QR Code Add Formweb to your mobile device
Android iOS
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary
Change Request Form Chemical/SDS Search UNC Health.org
Search results for:

ado-trastuzumab emtansine

ado-trastuzumab emtansine
Drug Name Form Strength ARHS Blue Ridge Caldwell Chatham Johnston Lenoir Medical Center Nash Pardee Rex Rockingham Southeastern Wayne Youth Behavioral Health
Ado-Trastuzumab Emtansine POWDER FOR INJECTION, INTRAVENOUS 100 mg                
Ado-Trastuzumab Emtansine POWDER FOR INJECTION, INTRAVENOUS 160 mg                    

UNC Health 

     Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies

     System Formulary Restriction:

Use of ado-trastuzumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)

     Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet

Med Center
     UNC Medical Center Formulary Restrictions

Last updated: Jul. 19, 2023






This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved